Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Source:http://linkedlifedata.com/resource/pubmed/id/10955784

Download in:

View as

General Info

PMID
10955784